4.6 Review

Nutraceuticals and Enteric Glial Cells

Journal

MOLECULES
Volume 26, Issue 12, Pages -

Publisher

MDPI
DOI: 10.3390/molecules26123762

Keywords

coffee; enteric glial cells; glia; inflammatory bowel disease; irritable bowel syndrome; neuropathic pain; nutraceuticals; quercetin; resveratrol

Funding

  1. Ministerio de Ciencia, Innovacion y Universidades [PID2019-111510RB-I00]
  2. National Science Center-SONATA 15 [UMO2019/35/D/NZ7/02830]

Ask authors/readers for more resources

Glia cells, previously seen as merely structural support for neurons, have been found to be equally as important, with enteric glial cells in the gastrointestinal tract playing essential roles in neuroprotection and immune system regulation. Nutraceuticals, defined as food substances providing health benefits, have shown potential as alternative methods for preventing and treating enteric gliopathies and associated gastrointestinal conditions, although studies in this area are currently limited.
Until recently, glia were considered to be a structural support for neurons, however further investigations showed that glial cells are equally as important as neurons. Among many different types of glia, enteric glial cells (EGCs) found in the gastrointestinal tract, have been significantly underestimated, but proved to play an essential role in neuroprotection, immune system modulation and many other functions. They are also said to be remarkably altered in different physiopathological conditions. A nutraceutical is defined as any food substance or part of a food that provides medical or health benefits, including prevention and treatment of the disease. Following the description of these interesting peripheral glial cells and highlighting their role in physiological and pathological changes, this article reviews all the studies on the effects of nutraceuticals as modulators of their functions. Currently there are only a few studies available concerning the effects of nutraceuticals on EGCs. Most of them evaluated molecules with antioxidant properties in systemic conditions, whereas only a few studies have been performed using models of gastrointestinal disorders. Despite the scarcity of studies on the topic, all agree that nutraceuticals have the potential to be an interesting alternative in the prevention and/or treatment of enteric gliopathies (of systemic or local etiology) and their associated gastrointestinal conditions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available